Published in Proc (Bayl Univ Med Cent) on July 01, 2008
Hepatocellular carcinoma in Japanese patients with nonalcoholic fatty liver disease, alcoholic liver disease, and chronic liver disease of unknown etiology: report of the nationwide survey. J Gastroenterol (2011) 1.06
Analysis of serum haptoglobin fucosylation in hepatocellular carcinoma and liver cirrhosis of different etiologies. J Proteome Res (2014) 1.05
Could metabolic syndrome lead to hepatocarcinoma via non-alcoholic fatty liver disease? World J Gastroenterol (2014) 0.99
Large-scale analysis of network bistability for human cancers. PLoS Comput Biol (2010) 0.95
Apoptotic and inhibitory effects on cell proliferation of hepatocellular carcinoma HepG2 cells by methanol leaf extract of Costus speciosus. Biomed Res Int (2014) 0.92
Proteomic dissection of cell type-specific H2AX-interacting protein complex associated with hepatocellular carcinoma. J Proteome Res (2010) 0.90
Multimodal treatment of hepatocellular carcinoma on cirrhosis: an update. World J Gastroenterol (2013) 0.89
Role of autophagy in differential sensitivity of hepatocarcinoma cells to sorafenib. World J Hepatol (2014) 0.84
Circulating microRNAs as biomarkers in hepatocellular carcinoma screening: a validation set from China. Medicine (Baltimore) (2015) 0.83
The Global Nonalcoholic Fatty Liver Disease Epidemic: What a Radiologist Needs to Know. J Clin Imaging Sci (2015) 0.82
The novel dual PI3K/mTOR inhibitor NVP-BGT226 displays cytotoxic activity in both normoxic and hypoxic hepatocarcinoma cells. Oncotarget (2015) 0.81
Update in management of hepatocellular carcinoma in Eastern population. World J Hepatol (2015) 0.81
A proteomic analysis of mushroom polysaccharide-treated HepG2 cells. Sci Rep (2016) 0.80
Can methanolic extract of Nigella sativa seed affect glyco-regulatory enzymes in experimental hepatocellular carcinoma? Environ Health Prev Med (2012) 0.78
Diagnosis and management of hepatocellular carcinoma: results of a consensus meeting of The Ottawa Hospital Cancer Centre. Curr Oncol (2010) 0.78
Genome-wide analysis of DNA methylation and gene expression patterns in purified, uncultured human liver cells and activated hepatic stellate cells. Oncotarget (2015) 0.78
Sequence-defined cMET/HGFR-targeted Polymers as Gene Delivery Vehicles for the Theranostic Sodium Iodide Symporter (NIS) Gene. Mol Ther (2016) 0.76
Immunobiology of hepatocarcinogenesis: Ways to go or almost there? World J Gastrointest Pathophysiol (2016) 0.76
Gemcitabine and Antisense-microRNA Co-encapsulated PLGA-PEG Polymer Nanoparticles for Hepatocellular Carcinoma Therapy. ACS Appl Mater Interfaces (2016) 0.75
Mortality assessment of patients with hepatocellular carcinoma according to underlying disease and treatment modalities. Medicine (Baltimore) (2017) 0.75
Comprehensive Comparison of Multiple-Detector Computed Tomography and Dynamic Magnetic Resonance Imaging in the Diagnosis of Hepatocellular Carcinoma with Varying Degrees of Fibrosis. PLoS One (2016) 0.75
Hypoxia-targeted 131I therapy of hepatocellular cancer after systemic mesenchymal stem cell-mediated sodium iodide symporter gene delivery. Oncotarget (2016) 0.75
Alginate-embedded HuH-7 cells increase MMP-9 and reduce OCLN expression in vitro. Cancer Cell Int (2017) 0.75
Evaluation of liver cirrhosis and hepatocellular carcinoma using Protein-Protein Interaction Networks. Gastroenterol Hepatol Bed Bench (2016) 0.75
Minimally invasive percutaneous endovascular therapies in the management of complications of non-alcoholic fatty liver disease (NAFLD): A case report. J Radiol Case Rep (2015) 0.75
Mechanotransduction in cancer. Curr Opin Chem Eng (2016) 0.75
Effect of cancer/testis antigen NY-SAR-35 on the proliferation, migration and invasion of cancer cells. Oncol Lett (2016) 0.75
Measuring levels of osteopontin as potential biomarker for hepatocellular carcinoma in Syrian patients. Gastroenterol Hepatol Bed Bench (2017) 0.75
Expression of connective tissue growth factor in the livers of non-viral hepatocellular carcinoma patients with metabolic risk factors. J Gastroenterol (2016) 0.75
Murine double minute 2, a potential p53-independent regulator of liver cancer metastasis. Hepatoma Res (2016) 0.75
Epidemiology and Synergistic Hepatopathology of Malaria and Hepatitis C Virus Coinfection. Virology (Auckl) (2017) 0.75
Management of hepatocellular carcinoma. Hepatology (2005) 27.42
Lessons from hereditary colorectal cancer. Cell (1996) 25.73
Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med (1996) 22.46
The 12-month prevalence and trends in DSM-IV alcohol abuse and dependence: United States, 1991-1992 and 2001-2002. Drug Alcohol Depend (2004) 13.53
Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production. Science (2007) 12.91
Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival. Hepatology (2003) 11.55
Primary liver cancer: worldwide incidence and trends. Gastroenterology (2004) 11.21
Lamivudine for patients with chronic hepatitis B and advanced liver disease. N Engl J Med (2004) 10.31
Hepatocellular carcinoma pathogenesis: from genes to environment. Nat Rev Cancer (2006) 10.05
Long-term follow-up of patients with NAFLD and elevated liver enzymes. Hepatology (2006) 10.05
Hepatocellular carcinoma in cirrhosis: incidence and risk factors. Gastroenterology (2004) 8.36
Regulation of interferon regulatory factor-3 by the hepatitis C virus serine protease. Science (2003) 7.91
Phase II study of sorafenib in patients with advanced hepatocellular carcinoma. J Clin Oncol (2006) 6.95
Sorafenib blocks the RAF/MEK/ERK pathway, inhibits tumor angiogenesis, and induces tumor cell apoptosis in hepatocellular carcinoma model PLC/PRF/5. Cancer Res (2006) 6.66
Inhibition of the interferon-inducible protein kinase PKR by HCV E2 protein. Science (1999) 6.21
Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival. Hepatology (2001) 6.19
Hepatocellular carcinoma: recent trends in the United States. Gastroenterology (2004) 5.90
Clinical outcomes after transfusion-associated hepatitis C. N Engl J Med (1995) 5.55
Morbidity and mortality in compensated cirrhosis type C: a retrospective follow-up study of 384 patients. Gastroenterology (1997) 5.53
Risk factors for hepatocellular carcinoma among patients with chronic liver disease. N Engl J Med (1993) 5.32
Randomized controlled trial of screening for hepatocellular carcinoma. J Cancer Res Clin Oncol (2004) 5.29
The association between hepatitis C infection and survival after orthotopic liver transplantation. Gastroenterology (2002) 4.98
An analysis of 412 cases of hepatocellular carcinoma at a Western center. Ann Surg (1999) 4.26
The association between diabetes and hepatocellular carcinoma: a systematic review of epidemiologic evidence. Clin Gastroenterol Hepatol (2006) 4.17
Cryptogenic cirrhosis: clinical characterization and risk factors for underlying disease. Hepatology (1999) 3.99
Projecting future complications of chronic hepatitis C in the United States. Liver Transpl (2003) 3.84
Estimating future hepatitis C morbidity, mortality, and costs in the United States. Am J Public Health (2000) 3.82
Sustained virological response to interferon-alpha is associated with improved outcome in HCV-related cirrhosis: a retrospective study. Hepatology (2007) 3.73
Survival and causes of death in cirrhotic and in noncirrhotic patients with primary hemochromatosis. N Engl J Med (1985) 3.73
Risk factors for hepatocellular carcinoma: synergism of alcohol with viral hepatitis and diabetes mellitus. Hepatology (2002) 3.59
Prognosis of chronic hepatitis C: results of a large, prospective cohort study. Hepatology (1998) 3.00
NAFLD may be a common underlying liver disease in patients with hepatocellular carcinoma in the United States. Hepatology (2002) 2.96
Alcohol and hepatocellular carcinoma: the effect of lifetime intake and hepatitis virus infections in men and women. Am J Epidemiol (2002) 2.94
Glypican-3: a novel serum and histochemical marker for hepatocellular carcinoma. Gastroenterology (2003) 2.90
Chemoembolization for hepatocellular carcinoma. Gastroenterology (2004) 2.89
Treatment and outcomes of treating of hepatocellular carcinoma among Medicare recipients in the United States: a population-based study. J Hepatol (2005) 2.85
Accuracy of ultrasonography, spiral CT, magnetic resonance, and alpha-fetoprotein in diagnosing hepatocellular carcinoma: a systematic review. Am J Gastroenterol (2006) 2.67
Systematic review: evidence-based management of hepatocellular carcinoma--an updated analysis of randomized controlled trials. Aliment Pharmacol Ther (2006) 2.63
Alcohol and hepatocellular carcinoma. Gastroenterology (2004) 2.61
Initial response to percutaneous ablation predicts survival in patients with hepatocellular carcinoma. Hepatology (2004) 2.54
Dysregulation of growth factor signaling in human hepatocellular carcinoma. Oncogene (2006) 2.49
Genetics of hepatocellular tumors. Oncogene (2006) 2.43
Hepatocellular carcinoma: recent trends in Japan. Gastroenterology (2004) 2.35
The natural history of compensated cirrhosis due to hepatitis C virus: A 17-year cohort study of 214 patients. Hepatology (2006) 2.35
A molecular signature to discriminate dysplastic nodules from early hepatocellular carcinoma in HCV cirrhosis. Gastroenterology (2006) 2.32
Long-term outcomes of cirrhosis in nonalcoholic steatohepatitis compared with hepatitis C. Hepatology (2003) 2.28
Radiofrequency ablation of liver tumors: a systematic review. Arch Surg (2006) 2.22
Hepatocellular carcinoma occurring in nonfibrotic liver: epidemiologic and histopathologic analysis of 80 French cases. Hepatology (2000) 2.21
Disease progression and hepatocellular carcinogenesis in patients with chronic viral hepatitis: a prospective observation of 2215 patients. J Hepatol (1998) 2.21
Hepatitis C-related hepatocellular carcinoma in the United States: influence of ethnic status. Am J Gastroenterol (2003) 2.18
Hepatocellular carcinoma. A worldwide problem and the major risk factors. Dig Dis Sci (1991) 2.12
Pathogenesis of hepatitis B virus-related hepatocellular carcinoma: old and new paradigms. Gastroenterology (2004) 2.11
Alpha-fetoprotein and ultrasonography screening for hepatocellular carcinoma. Gastroenterology (2004) 2.08
Incidence of hepatocellular carcinoma in chronic hepatitis B and C: a prospective study of 251 patients. Hepatology (1995) 2.06
New therapies for hepatocellular carcinoma. Oncogene (2006) 2.05
Des-gamma carboxyprothrombin can differentiate hepatocellular carcinoma from nonmalignant chronic liver disease in american patients. Hepatology (2003) 2.05
Survival, liver failure, and hepatocellular carcinoma in obesity-related cryptogenic cirrhosis. Hepatology (2002) 2.02
Screening for hepatocellular carcinoma in Alaska natives infected with chronic hepatitis B: a 16-year population-based study. Hepatology (2000) 1.95
Hepatitis C virus infection as a risk factor for hepatocellular carcinoma in patients with cirrhosis. A case-control study. Ann Intern Med (1992) 1.92
MRI angiography is superior to helical CT for detection of HCC prior to liver transplantation: an explant correlation. Hepatology (2003) 1.85
Semiannual and annual surveillance of cirrhotic patients for hepatocellular carcinoma: effects on cancer stage and patient survival (Italian experience). Am J Gastroenterol (2002) 1.85
Early detection of hepatocellular carcinoma in patients with chronic type B hepatitis. A prospective study. Gastroenterology (1986) 1.84
Hepatitis C virus related cirrhosis: time to occurrence of hepatocellular carcinoma and death. Gut (2000) 1.84
Prospective study of hepatocellular carcinoma and liver cirrhosis in asymptomatic chronic hepatitis B virus carriers. Am J Epidemiol (1997) 1.83
Serum tumor markers for detection of hepatocellular carcinoma. World J Gastroenterol (2006) 1.82
Subcutaneous seeding of hepatocellular carcinoma after percutaneous needle biopsy. Gut (1999) 1.82
Iron, hemochromatosis, and hepatocellular carcinoma. Gastroenterology (2004) 1.74
Effect of hepatitis B and C virus infections on the natural history of compensated cirrhosis: a cohort study of 297 patients. Am J Gastroenterol (2002) 1.74
Growth rate of asymptomatic hepatocellular carcinoma and its clinical implications. Gastroenterology (1985) 1.73
Prospective study of early detection of hepatocellular carcinoma in patients with cirrhosis. Hepatology (1990) 1.72
Independent and combined action of hepatitis C virus infection and alcohol consumption on the risk of symptomatic liver cirrhosis. Hepatology (1998) 1.69
Hepatocellular carcinoma: current surgical management. Gastroenterology (2004) 1.66
Assessment of the benefits and risks of percutaneous biopsy before surgical resection of hepatocellular carcinoma. J Hepatol (2001) 1.61
Yttrium-90 microspheres for the treatment of hepatocellular carcinoma. Gastroenterology (2004) 1.57
Epidemiological factors affecting the severity of hepatitis C virus-related liver disease: a French survey of 6,664 patients. The Study Group for the Prevalence and the Epidemiology of Hepatitis C Virus. Hepatology (1997) 1.55
Comparison of liver biopsy and noninvasive methods for diagnosis of hepatocellular carcinoma. Clin Gastroenterol Hepatol (2006) 1.49
Improved survival with screening for hepatocellular carcinoma. Liver Transpl (2000) 1.37
Liver cancer in Asian migrants to the United States and their descendants. Cancer Causes Control (1996) 1.34
Hepatitis B and C virus infection, alcohol drinking, and hepatocellular carcinoma: a case-control study in Italy. Brescia HCC Study. Hepatology (1997) 1.31
Cohort study of internal malignancy in genetic hemochromatosis and other chronic nonalcoholic liver diseases. J Natl Cancer Inst (1985) 1.31
Liver transplantation for hepatocellular carcinoma. Gastroenterology (2004) 1.24
Dynamic CT for detecting small hepatocellular carcinoma: usefulness of delayed phase imaging. AJR Am J Roentgenol (2007) 1.17
Survival and prognostic factors in 212 Italian patients with genetic hemochromatosis. Hepatology (1992) 1.16
The role of (18)F-FDG-PET imaging for the selection of liver transplantation candidates among hepatocellular carcinoma patients. Liver Transpl (2006) 1.15
Alpha fetoprotein, ultrasound, computerized tomography and magnetic resonance imaging for detection of hepatocellular carcinoma in patients with advanced cirrhosis. Aliment Pharmacol Ther (2007) 1.13
Hepatitis C virus core protein: possible roles in viral pathogenesis. Curr Top Microbiol Immunol (2000) 1.11
Expanded criteria for liver transplantation in patients with hepatocellular carcinoma: a report from the International Registry of Hepatic Tumors in Liver Transplantation. Liver Transpl (2007) 1.10
Cancer mortality among Chinese in the United States. J Natl Cancer Inst (1980) 1.10
Analysis of factors affecting the appearance of hepatocellular carcinoma in patients with chronic hepatitis C. A long term follow-up study after histologic diagnosis. Cancer (2000) 1.10
Etiology of hepatocellular carcinoma in Italian patients with and without cirrhosis. Cancer Epidemiol Biomarkers Prev (2000) 1.08
Molecular basis of hepatitis C virus-associated hepatocarcinogenesis: lessons from animal model studies. Clin Gastroenterol Hepatol (2005) 1.06
Detection of hypervascular hepatocellular carcinoma: Comparison of multi-detector CT with digital subtraction angiography and Lipiodol CT. World J Gastroenterol (2005) 1.05
Long-term outcome of hepatitis B e antigen-positive patients with compensated cirrhosis treated with interferon alfa. European Concerted Action on Viral Hepatitis (EUROHEP). Hepatology (1997) 1.04
Application of superparamagnetic iron oxide to imaging of hepatocellular carcinoma. Eur J Radiol (2006) 1.03
Effect of aflatoxin metabolism and DNA adduct formation on hepatocellular carcinoma among chronic hepatitis B carriers in Taiwan. J Hepatol (1997) 1.02
Computed tomographic imaging of hepatocellular carcinoma. Gastroenterology (2004) 1.01
High-dose proton beam radiotherapy of hepatocellular carcinoma: preliminary results of a phase II trial. Gastroenterology (2004) 1.01
Clinical evaluation of plasma des-gamma-carboxy prothrombin as a marker protein of hepatocellular carcinoma in patients with tumors of various sizes. Dig Dis Sci (1993) 0.99
Clinical evaluation of lentil lectin-reactive alpha-fetoprotein-L3 in histology-proven hepatocellular carcinoma. Int J Biol Markers (2001) 0.98
Identification of transcriptional regulators in the mouse immune system. Nat Immunol (2013) 1.79
The transcriptional landscape of αβ T cell differentiation. Nat Immunol (2013) 1.61
Patients with NASH and cryptogenic cirrhosis are less likely than those with hepatitis C to receive liver transplants. Clin Gastroenterol Hepatol (2011) 1.57
Twenty years of follow-up of aortohepatic conduits in liver transplantation. Liver Transpl (2008) 1.53
GREIT: a unified approach to 2D linear EIT reconstruction of lung images. Physiol Meas (2009) 1.52
Preoperative and perioperative predictors of the need for renal replacement therapy after orthotopic liver transplantation. Transplantation (2004) 1.50
Syndromic incidence of ovarian carcinoma after liver transplantation, with special reference to anteceding breast cancer. Dig Dis Sci (2003) 1.43
Professional identity in community mental health nursing: a thematic analysis. Int J Nurs Stud (2007) 1.42
Assessing water quality at large geographic scales: relations among land use, water physicochemistry, riparian condition, and fish community structure. Environ Manage (2003) 1.38
Thrombendvenectomy for organized portal vein thrombosis at the time of liver transplantation. Ann Surg (2002) 1.24
Ex vivo gene therapy for hemophilia A that enhances safe delivery and sustained in vivo factor VIII expression from lentivirally engineered endothelial progenitors. Stem Cells (2007) 1.22
A correlation between the pretransplantation MELD score and mortality in the first two years after liver transplantation. Liver Transpl (2003) 1.20
Long-term outcomes of stereotactic body radiation therapy in the treatment of hepatocellular cancer as a bridge to transplantation. Liver Transpl (2012) 1.18
The effect of amblyopia on fine motor skills in children. Invest Ophthalmol Vis Sci (2008) 1.17
Predicting renal failure after liver transplantation from measured glomerular filtration rate: review of up to 15 years of follow-up. Transplantation (2010) 1.13
Therapeutic factor VIII levels and negligible toxicity in mouse and dog models of hemophilia A following gene therapy with high-capacity adenoviral vectors. Blood (2002) 1.11
An outcome comparison between primary liver transplantation and retransplantation based on the pretransplant MELD score. Transpl Int (2006) 1.11
A microRNA-regulated and GP64-pseudotyped lentiviral vector mediates stable expression of FVIII in a murine model of Hemophilia A. Mol Ther (2011) 1.11
Expanded criteria for liver transplantation in patients with hepatocellular carcinoma: a report from the International Registry of Hepatic Tumors in Liver Transplantation. Liver Transpl (2007) 1.10
'Am I normal?' Teenagers, sexual health and the internet. Soc Sci Med (2007) 1.09
Pretransplant MELD score as a predictor of outcome after liver transplantation for chronic hepatitis C. Am J Transplant (2003) 1.05
Glaucoma detection is facilitated by luminance modulation of the global flash multifocal electroretinogram. Invest Ophthalmol Vis Sci (2006) 1.02
Multidisciplinary treatment of a large cerebral dural arteriovenous fistula using embolization, surgery, and radiosurgery. Proc (Bayl Univ Med Cent) (2008) 1.02
De novo tumors after liver transplantation: a single-institution experience. Liver Transpl (2002) 1.00
Two-stage total hepatectomy and liver transplantation for acute deterioration of chronic liver disease: a new bridge to transplantation. Liver Transpl (2004) 1.00
A new threat to honey bees, the parasitic phorid fly Apocephalus borealis. PLoS One (2012) 0.99
Liver retransplantation for primary nonfunction: analysis of a 20-year single-center experience. Liver Transpl (2007) 0.99
Late acute rejection after liver transplantation impacts patient survival. Clin Transplant (2008) 0.96
Liver and kidney transplantation for polycystic liver and kidney-renal function and outcome. Transplantation (2006) 0.96
Porcine global flash multifocal electroretinogram: possible mechanisms for the glaucomatous changes in contrast response function. Vision Res (2008) 0.94
The rod-mediated multifocal electroretinogram in aging and in early age-related maculopathy. Curr Eye Res (2006) 0.93
Impact of tacrolimus versus cyclosporine in hepatitis C virus-infected liver transplant recipients on recurrent hepatitis: a prospective, randomized trial. Liver Transpl (2004) 0.93
Hepatorenal syndrome: a proposal for kidney after liver transplantation (KALT). Liver Transpl (2007) 0.93
The autonomic control of accommodation and implications for human myopia development: a review. Ophthalmic Physiol Opt (2003) 0.93
Short-term in-office practice improves reading performance with stand magnifiers for people with AMD. Optom Vis Sci (2005) 0.91
Societal reintegration after liver transplantation: findings in alcohol-related and non-alcohol-related transplant recipients. Ann Surg (2004) 0.90
Incidence and recurrence of autoimmune/alloimmune hepatitis in liver transplant recipients. Liver Transpl (2002) 0.90
Correlation between intraoperative blood flows and hepatic artery strictures in liver transplantation. Liver Transpl (2002) 0.90
Heterogeneity of the immune response to adenovirus-mediated factor VIII gene therapy in different inbred hemophilic mouse strains. J Gene Med (2004) 0.89
The changing clinical presentation of recurrent primary biliary cirrhosis after liver transplantation. Transplantation (2003) 0.89
Liver transplantation and health-related quality of life: scoring differences between men and women. Liver Transpl (2004) 0.88
Hematologic aspects of liver transplantation for Budd-Chiari syndrome with special reference to myeloproliferative disorders. Transplantation (2002) 0.88
The effects of forward light scattering on the multifocal electroretinogram. Curr Eye Res (2004) 0.87
Clinical outcomes from hepatic artery stenting in liver transplantation. Liver Transpl (2006) 0.87
Factors that influence the medication decision making of persons with HIV/AIDS: a taxonomic exploration. J Assoc Nurses AIDS Care (2003) 0.87
Radiofrequency thermal ablation of hepatocellular carcinoma before liver transplantation--a clinical and histological examination. Clin Transplant (2006) 0.86
Luminance-modulated adaptation of global flash mfERG: fellow eye losses in asymmetric glaucoma. Invest Ophthalmol Vis Sci (2007) 0.86
Small renal mass biopsy--how, what and when: report from an international consensus panel. BJU Int (2014) 0.86
Effect of amblyopia on self-esteem in children. Optom Vis Sci (2008) 0.86
Indications for combined liver and kidney transplantation: propositions after a 23-yr experience. Clin Transplant (2010) 0.85
Functional outcomes after multiple treatments with ranibizumab in neovascular age-related macular degeneration beyond visual acuity. Clin Ophthalmol (2007) 0.84
Improved results of transplantation for hepatocellular carcinoma: a report from the International Registry of Hepatic Tumors in Liver Transplantation. Liver Transpl (2009) 0.82
Adaptation responses in early age-related maculopathy. Invest Ophthalmol Vis Sci (2005) 0.82
Treatment of unresectable hepatoblastoma with liver transplantation in the pediatric population. Am J Transplant (2002) 0.82
Liver transplantation for cholestasis associated with cystic fibrosis in the pediatric population. Pediatr Transplant (2003) 0.82
Health communication and adolescents: what do their emails tell us? Fam Pract (2008) 0.82
Local neuroretinal function during acute hypoxia in healthy older people. Invest Ophthalmol Vis Sci (2008) 0.81
Changes in implicit time of the multifocal electroretinogram response following contrast adaptation. Curr Eye Res (2006) 0.81
Effect of amblyopia on the Developmental Eye Movement test in children. Optom Vis Sci (2009) 0.81
Preferred walking speed for assessment of mobility performance: sighted guide versus non-sighted guide techniques. Clin Exp Optom (2002) 0.81
Robotically guided radiosurgery for children. Pediatr Blood Cancer (2005) 0.80
Retinal adaptation responses revealed by global flash multifocal electroretinogram are dependent on the degree of myopic refractive error. Vision Res (2006) 0.80
Comparing the multifocal electroretinogram topography before and after cataract surgery. Curr Eye Res (2005) 0.79
Long-term follow-up of liver transplantation for Budd-Chiari syndrome with antithrombotic therapy based on the etiology. Transplantation (2011) 0.79
Successful combined liver and kidney transplant for COACH syndrome and 5-yr follow-up. Clin Transplant (2005) 0.79
Cadaveric orthotopic auxiliary split liver transplantation and kidney transplantation: an alternative for type 1 primary hyperoxaluria. Transplantation (2005) 0.79
False aneurysm of a hepatic artery branch complicating intrahepatic islet transplantation. Transpl Int (2009) 0.79
Immunosuppression for delayed or slow graft function in primary cadaveric renal transplantation: use of low dose tacrolimus therapy with post-operative administration of anti-CD25 monoclonal antibody. Clin Transplant (2002) 0.79
Cone-mediated multifocal electroretinogram in early age-related maculopathy and its relationships with subjective macular function tests. Curr Eye Res (2004) 0.79
Pepsinogen C expression in intestinal IEC-6 cells. Cell Physiol Biochem (2003) 0.79
Objective functional assessment of age-related maculopathy: a special application for the multifocal electroretinogram. Clin Exp Optom (2005) 0.79
Slow flash multifocal electroretinogram in myopia. Vision Res (2006) 0.78
Sacrificing the personal to the professional: community mental health nurses. J Adv Nurs (2003) 0.78
New frontiers in radiosurgery for the brain and body. Proc (Bayl Univ Med Cent) (2005) 0.78
Sirolimus and cardiovascular disease risk in liver transplantation. Transplantation (2013) 0.78
Luminance-modulated adaptation in the global flash mfERG: a preliminary study of early retinal functional changes in high-risk glaucoma patients. Graefes Arch Clin Exp Ophthalmol (2011) 0.78
Feasibility of radiosurgery for malignant brain tumors in infants by use of image-guided robotic radiosurgery: preliminary report. Neurosurgery (2004) 0.78
Baylor Regional Transplant Institute: an update on liver, kidney, and pancreas transplantation. Proc (Bayl Univ Med Cent) (2003) 0.78
Delayed mfERG responses in myopia. Vision Res (2005) 0.78
Relationship Among CFH and ARMS2 Genotypes, Macular Pigment Optical Density, and Neuroretinal Function in Persons Without Age-Related Macular Degeneration. Arch Ophthalmol (2012) 0.78
Twenty years' follow-up of portal vein conduits in liver transplantation. Liver Transpl (2009) 0.78
Compensations for increased rotational inertia during human cutting turns. J Exp Biol (2013) 0.78
Intraoperative imaging of pancreas transplant allografts using indocyanine green with laser fluorescence. Proc (Bayl Univ Med Cent) (2008) 0.78
Dynamics of retinal function after multiple photodynamic therapies in age-related macular degeneration: a report of cases. Doc Ophthalmol (2006) 0.77
Reduced sampling efficiency causes degraded Vernier hyperacuity with normal aging: Vernier acuity in position noise. Sci Rep (2012) 0.77
Implications of a positive crossmatch in liver transplantation: a 20-year review. Liver Transpl (2012) 0.77
Reluctant empiricists: community mental health nurses and the art of evidence-based praxis. Health Soc Care Community (2002) 0.77
The effect of a beta-adrenoceptor antagonist on accommodative adaptation in Hong Kong children. Curr Eye Res (2005) 0.77
Evaluation of inner retinal function in myopia using oscillatory potentials of the multifocal electroretinogram. Vision Res (2006) 0.77
The design of compassionate care. J Clin Nurs (2014) 0.77
Fast healthcare: brief communication, traps and opportunities. Patient Educ Couns (2010) 0.76
Liver transplantation for cystic fibrosis in adults. Surg Today (2007) 0.76
The effect of common reductions in letter size and contrast on accommodation responses in young adult myopes and emmetropes. Optom Vis Sci (2005) 0.76
Effect of unilateral forced nostril breathing on tonic accommodation and intraocular pressure. Clin Auton Res (2004) 0.76
Experimental hypoxia in human eyes: implications for ischaemic disease. Clin Neurophysiol (2007) 0.76
DEM test, visagraph eye movement recordings, and reading ability in children. Optom Vis Sci (2011) 0.75
Use of two expanded-criteria-donor renal allografts in a single patient. Proc (Bayl Univ Med Cent) (2007) 0.75